A cadre of venture capital firms could cash in from the wave of Bay Area biotech initial public offerings in the first half of the year.
Stalwart VCs such as Kleiner Perkins Caufield & Byers of Menlo Park and Domain Associates are among the venture capital firms whose names pop up most often in the IPOs of local life sciences companies through June. Among the other VCs are DAG Ventures of Palo Alto and Essex Woodlands Health Ventures in Palo Alto.
{iframe}http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/07/ipo-kleiner-perkins-caufield-byers-domain-tpg-nea.html{/iframe}